ING1 and breast carcinoma: When taking the total population of the cohort into account, stromal ING1 (HR 2.125, p = 0.004) not only came out to be an independent prognostic marker for breast cancer, but had better predictive power than already established biomarkers like HER2, ER and tumor size, which are commonly used in the clinic.